Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ABBOTT INDIA   TEVA PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-23
TEVA PHARMA
Dec-13
ABBOTT INDIA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs22,4823,486-   
Low Rs16,1563,028-   
Sales per share (Unadj.) Rs2,517.02,000.5-  
Earnings per share (Unadj.) Rs446.8125.0-  
Cash flow per share (Unadj.) Rs479.7286.7-  
Dividends per share (Unadj.) Rs325.00109.40-  
Avg Dividend yield %1.73.4 50.1%  
Book value per share (Unadj.) Rs1,480.52,222.2-  
Shares outstanding (eoy) m21.25848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.71.6 471.4%   
Avg P/E ratio x43.226.1 165.9%  
P/CF ratio (eoy) x40.311.4 354.5%  
Price / Book Value ratio x13.01.5 890.3%  
Dividend payout %72.787.5 83.1%   
Avg Mkt Cap Rs m410,5132,761,843 14.9%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m5,6360-   
Avg. sales/employee Rs Th037,744.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,357.9-  
INCOME DATA
Net Sales Rs m53,4871,696,422 3.2%  
Other income Rs m1,5430-   
Total revenues Rs m55,0301,696,422 3.2%   
Gross profit Rs m12,055464,566 2.6%  
Depreciation Rs m700137,123 0.5%   
Interest Rs m16033,320 0.5%   
Profit before tax Rs m12,738294,122 4.3%   
Minority Interest Rs m01,336 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-193,075 -0.0%   
Tax Rs m3,244-3,591 -90.3%   
Profit after tax Rs m9,494105,974 9.0%  
Gross profit margin %22.527.4 82.3%  
Effective tax rate %25.5-1.2 -2,086.0%   
Net profit margin %17.86.2 284.1%  
BALANCE SHEET DATA
Current assets Rs m30,2511,145,757 2.6%   
Current liabilities Rs m12,060999,197 1.2%   
Net working cap to sales %34.08.6 393.7%  
Current ratio x2.51.1 218.7%  
Inventory Days Days8791 95.7%  
Debtors Days Days296 2.3%  
Net fixed assets Rs m15,135554,089 2.7%   
Share capital Rs m2134,176 5.1%   
"Free" reserves Rs m31,2480-   
Net worth Rs m31,4601,884,403 1.7%   
Long term debt Rs m0867,418 0.0%   
Total assets Rs m45,3863,876,868 1.2%  
Interest coverage x80.79.8 820.8%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.20.4 269.3%   
Return on assets %21.33.6 592.0%  
Return on equity %30.25.6 536.6%  
Return on capital %41.04.9 831.4%  
Exports to sales %0.40-   
Imports to sales %10.80-   
Net fx Rs m-5,5080-   
CASH FLOW
From Operations Rs m8,934270,322 3.3%  
From Investments Rs m-1,477-95,786 1.5%  
From Financial Activity Rs m-6,387-324,269 2.0%  
Net Cashflow Rs m1,070-149,733 -0.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare ABBOTT INDIA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ABBOTT INDIA With: PARENT.DRUGS  EVEREST ORGANICS  BETA DRUGS   SOURCE NATURAL FOODS  NUTRAPLUS PR  



Today's Market

Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red(10:30 am)

Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.